Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Onodera

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|May 31, 2022
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosisKoya Ono, Tohru Fujiwara, Kei Saito, et al.
Transplantation and Cellular Therapy|September 20, 2023
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic AnemiaYasushi Onishi, Takehiko Mori, Hirohito Yamazaki, et al.
Transplantation and Cellular Therapy|January 19, 2024
Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective StudyMasahiro Onozawa, Shigeru Kusumoto, Yuho Najima, et al.
International Journal of Hematology|November 21, 2024
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromesHiroshi Kosugi, Tomoaki Fujisaki, Hiromi Iwasaki, et al.
Annals of Hematology|May 15, 2024
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemiaYukinori Nakamura, Yoshitaka Zaimoku, Hiroki Yamaguchi, et al.
The New England Journal of Medicine|April 13, 2022
Mitapivat versus Placebo for Pyruvate Kinase DeficiencyHanny Al-Samkari, Frédéric Galactéros, Andreas Glenthøj, et al.
Transplantation and Cellular Therapy|April 13, 2026
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemiaYasuyuki Arai, Marie Ohbiki, Mio Kurata, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
American Journal of Hematology|September 5, 2025
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic AnemiaYoshitaka Zaimoku, Hirohito Yamazaki, Minoru Kanaya, et al.
Cancer|November 5, 2024
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationYosuke Okada, Noriaki Tachi, Yutaka Shimazu, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|May 31, 2022
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosisKoya Ono, Tohru Fujiwara, Kei Saito, et al.
Transplantation and Cellular Therapy|September 20, 2023
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic AnemiaYasushi Onishi, Takehiko Mori, Hirohito Yamazaki, et al.
Transplantation and Cellular Therapy|January 19, 2024
Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective StudyMasahiro Onozawa, Shigeru Kusumoto, Yuho Najima, et al.
International Journal of Hematology|November 21, 2024
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromesHiroshi Kosugi, Tomoaki Fujisaki, Hiromi Iwasaki, et al.
Annals of Hematology|May 15, 2024
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemiaYukinori Nakamura, Yoshitaka Zaimoku, Hiroki Yamaguchi, et al.
The New England Journal of Medicine|April 13, 2022
Mitapivat versus Placebo for Pyruvate Kinase DeficiencyHanny Al-Samkari, Frédéric Galactéros, Andreas Glenthøj, et al.
Transplantation and Cellular Therapy|April 13, 2026
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemiaYasuyuki Arai, Marie Ohbiki, Mio Kurata, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
American Journal of Hematology|September 5, 2025
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic AnemiaYoshitaka Zaimoku, Hirohito Yamazaki, Minoru Kanaya, et al.
Cancer|November 5, 2024
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationYosuke Okada, Noriaki Tachi, Yutaka Shimazu, et al.
Pageof 6